Mar 2, 2023

RRBS service now validated on NovaSeq6000


RRBS method (Ovation RRBS Methyl-Seq with TrueMethyl oxBS, Tecan) is now tested and validated on NovaSeq6000 for sequencing offering cheaper methylation analysis

Reduced representation bisulfite sequencing (RRBS) is an efficient and high-throughput technique for analysing the genome-wide methylation profiles on a single nucleotide level. GCF has offered an RRBS service using the NextSeq500 instrument. We have now validated this assay using the Illumina NovaSeq6000 platform, which decreases sequencing costs for methylation analysis. The Ovation Methyl-Seq workflow combines stagger to eliminate low sequence diversity and increases base quality and UMI’s to account for non-unique reads from the data set. The required input material is 100 ng genomic DNA, from purified high-quality material to FFPE DNA.

           

 
 
 
 


News

Jun 1, 2024

The Genomics Core Facility will not accept new sample submissions over the summer break. The deadline for submission is noon on Friday, July 5th. We will reopen on Tuesday, July 30th. The sequencing of existing projects will continue, although turnaround times may be longer than usual.

We wish all our users a good summer

May 23, 2024

The First Visium HD service was performed this week. High demand for this new technology to study spatial biology at single–cell–scale resolution.


Contact Information:

Genomics@rr-research.no

Daily Leader Core Facility
Susanne Lorenz, PhD

Susanne.Lorenz@rr-research.no

Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.

L.A.Meza-Zepeda@ous-research.no

Follow us via Twitter

@OSLOmicsCore

Visiting address:

Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building 
 
Norwegian Radium Hospital 
Ullernchaussen 66, Lamell 3, 2B 
NO-0379 Oslo, NORWAY

+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office

................................................................